INTERNATIONAL NEUROLOGICAL KETOGENIC SOCIETY
(1) promoting the practice, science, global accessibility and implementation of ketogenic dietary therapies for the treatment of epilepsy and the specific neurometabolic disorder GLUT1 deficiency syndrome;(2) promoting research into ketogenic and metabolic therapies for the treatment of brain disorders(3) educating healthcare professionals about ketogenic and metabolic therapies
Objects
THE ADVANCEMENT OF HEALTH FOR THE PUBLIC BENEFIT BY: (1) PROMOTING THE PRACTICE, SCIENCE, GLOBAL ACCESSIBILITY AND IMPLEMENTATION OF KETOGENIC DIETARY THERAPIES FOR THE TREATMENT OF EPILEPSY AND THE SPECIFIC NEUROMETABOLIC DISORDER GLUT1 DEFICIENCY SYNDROME; (2) PROMOTING RESEARCH INTO KETOGENIC AND METABOLIC THERAPIES FOR THE TREATMENT OF BRAIN DISORDERS AND THE PUBLICATION OF THE USEFUL RESULTS OF SUCH RESEARCH THROUGH COLLABORATION AND EDUCATION; (3) EDUCATING HEALTHCARE PROFESSIONALS ABOUT KETOGENIC AND METABOLIC THERAPIES INCLUDING BY MANAGING AND FACILITATING THE BIENNIAL KETOGENIC THERAPIES GLOBAL SYMPOSIA SERIES.
Financial health, per its FY2025 accounts
The charity reported a net incoming resource of £14,007 for the year, increasing its unrestricted funds to £71,888. The trustees consider the financial performance satisfactory and state there are no material uncertainties regarding the charity's ability to continue. Reserves are held at £71,888, significantly above the trustees' stated retention policy target of £20,000.
What the accounts disclose
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Funders the charity credits
- The Charlie Foundation
- Matthew’s Friends
Trustees
- Dr Anita Devlinchair
- Beth Zupec-Kania
- Dr Marisa Armeno
- Professor J Helen Cross MBChBPhD
- Richard Alan Aldridge CA
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £30k | £16k |
| 30/06/2024 | £11k | £9k |
| 30/06/2023 | £67k | £11k |
Common questions
Is INTERNATIONAL NEUROLOGICAL KETOGENIC SOCIETY financially healthy?
Per its FY2025 accounts: The charity reported a net incoming resource of £14,007 for the year, increasing its unrestricted funds to £71,888. The trustees consider the financial performance satisfactory and state there are no material uncertainties regarding the charity's ability to continue. Reserves are held at £71,888, significantly above the trustees' stated retention policy target of £20,000. Its FY2025 accounts were independently examined.